Skip to main content
Clinical Trials/CTRI/2021/07/034821
CTRI/2021/07/034821
Completed
Phase 4

Comparative evaluation of intraoperative lung protective strategy in the COVID 19 recovered patients undergoingsurgery under GA to reduce short term and long term pulmonary complications Pilot study

SGPGIMS0 sites60 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: J984- Other disorders of lung
Sponsor
SGPGIMS
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
February 8, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
SGPGIMS

Eligibility Criteria

Inclusion Criteria

  • Patients of either sex with American Society Anaesthesiologists’ physical status I\-II, age between 18 and 70 years, with history of COVID 19 positive more than 3 months duration needed hospitalization and oxygen therapy during active phase) scheduled for surgery under general anaesthesia

Exclusion Criteria

  • The patient with presence of active respiratory tract infection, chronic obstructive lung disease, bronchial asthma and sleep apnoea syndrome, severe cardiovascular diseases, liver or kidney dysfunction, history of second\- or third\-degree heart block and ischemic heart diseases, body mass index \>35 kg/m2 and surgery more than 3 lumbar segments will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials